Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/05/307   
Active ingredient: Mecasermin
Indication: Treatment of primary growth hormone insensitivity syndrome
Sponsor: Ipsen Pharma
65 quai Georges Gorse, 92100 Boulogne-Billancourt, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/08/2005 Orphan designation EMEA/OD/025/05 (2005)3318 of 26/08/2005
16/12/2005 Transfer of orphan designation EMEA/OD/025/05/T/01 (2005)5628 of 14/12/2005
05/07/2007 Change of name and/or address of sponsor
15/09/2009 Transfer of orphan designation EMEA/OD/025/05/T/02 (2009)7039 of 14/09/2009